Search | IOVS | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Canadian Treat-and-Extend Trial with Ranibizumab in nAMD Patients: CANTREAT 36 Month Anatomic Outcomes

Peter Kertes; Tom Sheidow; Geoff Williams; Mark Greve; Ivan Galic; Jason Baker

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3501. doi:

ARVO Annual Meeting Abstract July 2019

Intraocular pressure trends in the Canadian treat and extend trial with ranibizumab in patients with nAMD: CANTREAT study 24-month results

Peter Kertes; Tom Sheidow; Geoff Williams; Mark Greve; Ivan Galic; Emmanouil Rampakakis; Marcel Lahaie

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):131. doi:

ARVO Annual Meeting Abstract July 2018

MACULAR HOLE AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR

Rayan Alshareef; Nastaran Nashki; Geoff Williams; Amin Kherani

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4252. doi:

ARVO Annual Meeting Abstract July 2018

Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: CANTREAT Study One Year Results

Peter Kertes; Tom Sheidow; Geoff Williams; Mark Greve; Ivan John Galic; Emmanouil Rampakakis; Joanne Gavalakis; Andrea Scarino

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1622. doi:

ARVO Annual Meeting Abstract June 2017

Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: Interim Analysis of the CANTREAT Study

Peter Kertes; Thomas G Sheidow; Geoff Williams; Mark Greve; Ivan Galic; Emmanouil Rampakakis; Joanne Gavalakis; Andrea Scarino

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1200. doi:

ARVO Annual Meeting Abstract September 2016

Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: Interim Analysis of the CANTREAT Study

Peter Kertes; Tom Sheidow; Geoff Williams; Mark Greve; Ivan John Galic; Emmanouil Rampakakis; Bernard Bourgault; Anne-Sophie Courseau

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):538. doi:

ARVO Annual Meeting Abstract June 2013

A comparison of spectral domain optical coherence tomography and multifocal electroretinography findings in hydroxychloroquine retinopathy

Mark Seamone; Katherine Milton; Micheline Deschenes; Michael Fielden; Amin Kherani; R Geoff Williams; Calgary Retina Consultants

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3597. doi:

Advertisement